Amvis Holdings.Inc. (7071) AI Stock Analysis

• Market Cap: ¥46.40B
• Dividend Yield: 0.85%
• Average Volume (3M): 830.99K
• Price to Earnings (P/E): 6.6
• Beta (1Y): 0.81
• Revenue Growth: 30.50%
• EPS Growth: 3.57%
• Country: JP
• Employees: 4,046
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 98,313,600
• 10 Day Avg. Volume: 682,510
• 30 Day Avg. Volume: 830,990
• PEG Ratio: 0.00
• Price to Book (P/B): 38.97
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -56.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 75 Outperform
• Price Target: ¥540.00 ▲(14.41%Upside)

Amvis Holdings Inc. scores favorably overall, driven by strong financial performance and attractive valuation. The company's robust revenue growth and profitability margins are significant strengths, although increasing debt levels and cash flow challenges warrant caution. Technical indicators suggest moderate positive momentum, but potential overbought conditions need monitoring.

Amvis Holdings.Inc. Business Overview & Revenue Model

Company Description

Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Amvis Holdings Inc. generates revenue through its comprehensive suite of healthcare services, primarily focusing on home medical care. The company earns money by providing medical personnel, such as doctors and nurses, to visit patients at home, enabling personalized medical treatment and support. Additionally, Amvis Holdings Inc. leverages strategic partnerships with healthcare facilities and insurance companies to enhance service delivery and expand its client base, further contributing to its revenue streams.

Amvis Holdings.Inc. Financial Statement Overview

Summary

Amvis Holdings Inc. demonstrates strong revenue growth and healthy profit margins, with a notable TTM revenue increase of 32.8% and solid operational efficiency. However, the balance sheet shows a manageable yet increasing debt-to-equity ratio, and cash flow challenges are evident with zero free cash flow reported, highlighting areas for improvement in cash management.

Income Statement

Amvis Holdings Inc. demonstrates robust financial performance with steady revenue growth, as indicated by a significant TTM revenue of 44.7 billion JPY compared to 31.9 billion JPY in the previous annual period, marking a growth rate of approximately 32.8%. The gross profit margin remains strong at 38.3% in TTM, reflecting effective cost management. The net profit margin is healthy at 15.6% in TTM, though there has been a slight decline from previous periods, suggesting some pressure on net income. EBIT and EBITDA margins are also solid at 22.3% and 26.5% respectively, showcasing operational efficiency.

Balance Sheet

The balance sheet of Amvis Holdings Inc. indicates a strong equity position with a debt-to-equity ratio of 0.99 in TTM, which is manageable, though it has increased compared to previous years. The company's equity ratio stands at 45.9%, reflecting a balanced capital structure. Return on equity is impressive at 20.6% in TTM, indicating effective use of shareholder funds. However, the increased total debt level may pose potential risks if not managed carefully.

Cash Flow

Cash flow analysis reveals challenges, as the company reports a zero free cash flow in TTM, indicating issues in cash generation after investments. The operating cash flow to net income ratio is unavailable due to missing data, which makes it difficult to assess cash flow efficiency. Historical data shows a negative trend in free cash flow, highlighting the need for improved cash management.

Breakdown
TTM	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement		Total Revenue
44.71B	42.48B	31.98B	23.07B	15.33B	9.17B
	Gross Profit
17.13B	17.06B	13.27B	9.69B	6.30B	3.75B
	EBIT
9.99B	10.61B	8.63B	6.13B	3.78B	1.88B
	EBITDA
11.98B	12.76B	10.39B	7.10B	4.48B	2.17B
	Net Income Common Stockholders
6.97B	7.44B	6.31B	4.28B	2.63B	1.24B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
10.90B	8.87B	12.13B	11.34B	11.19B	3.33B
	Total Assets
64.95B	71.80B	55.56B	41.77B	31.92B	16.52B
	Total Debt
29.05B	31.75B	23.05B	17.43B	12.75B	9.55B
	Net Debt
18.14B	22.88B	10.93B	6.09B	1.56B	6.21B
	Total Liabilities
34.92B	38.59B	29.04B	21.31B	15.58B	11.27B
	Stockholders Equity
30.03B	33.21B	26.52B	20.46B	16.34B	5.25B
Cash Flow		Free Cash Flow
0.00	-8.52B	-3.06B	-2.73B	-2.79B	-3.78B
	Operating Cash Flow
0.00	7.48B	6.80B	4.42B	2.58B	1.17B
	Investing Cash Flow
0.00	-16.83B	-10.31B	-7.75B	-5.78B	-5.30B
	Financing Cash Flow
0.00	6.08B	4.30B	3.49B	11.05B	7.02B

Amvis Holdings.Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 472.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Neutral. The current price of 472 is above the 20-day moving average (MA) of 450.95, above the 50-day MA of 448.66, and below the 200-day MA of 1021.22, indicating a neutral trend. The MACD of 5.61 indicates Negative momentum. The RSI at 55.63 is Neutral, neither overbought nor oversold. The STOCH value of 60.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7071.

Amvis Holdings.Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7071	75 Outperform	¥46.40B	6.64		0.85%	30.50%	3.57%
Sector *	54 Neutral	$5.37B	3.26	-45.10%	3.30%	16.81%	0.02%
25E		€296.30M	19.04	20.85%	1.71%	―	―
6062	76 Outperform	¥40.83B	9.60		2.40%	7.94%	8.41%
9158	74 Outperform	¥32.98B	10.53		―	42.45%	20.44%
2374	73 Outperform	¥19.43B	12.88		3.86%	4.15%	-25.66%
6197	67 Neutral	¥40.08B	9.85		4.73%	1.70%	83.73%

Amvis Holdings.Inc. Corporate Events

Amvis Holdings Granted Extension for Semiannual Report Submission

Amvis Holdings, Inc. has received approval to extend the deadline for submitting its semiannual report for the fiscal year ending September 2025. The new deadline is set for August 14, 2025, allowing the company to complete necessary investigations and reviews. This extension aims to ensure accurate reporting and maintain transparency with stakeholders, despite any concerns this delay may cause.

Amvis Holdings Seeks Extension for Semiannual Report Amid Investigation

Amvis Holdings, Inc. has applied for an extension to submit its semiannual report for the fiscal year ending September 2025 due to an ongoing investigation into improper medical fee claims at its nursing facilities. The investigation, led by an independent Special Investigation Committee, is extensive and involves digital forensics, data analysis, and interviews, necessitating more time to ensure thoroughness, with the report expected by the extended deadline of August 14, 2025.

Amvis Holdings Delays Financial Results Amid Investigation

Amvis Holdings, Inc. has postponed its financial results announcement for the first half of the fiscal year ending September 30, 2025, due to an ongoing investigation into allegations of improper medical service fee claims. The delay is necessary to allow a Special Investigation Committee to conduct thorough research, including interviews and document analysis, across its 119 facilities, which may impact stakeholders’ confidence and the company’s market position.